Terms: = Bone cancer AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1 AND Prognosis
25 results:
1. miR-1293 suppresses osteosarcoma progression by modulating drug sensitivity in response to cisplatin treatment.
Wang T; Huang J; Chen G; Fu J; Li T; Zou X; Yi H
Int Immunopharmacol; 2024 Mar; 130():111702. PubMed ID: 38367464
[TBL] [Abstract] [Full Text] [Related]
2. Deletion of osteopontin in non-small cell lung cancer cells affects bone metabolism by regulating miR-34c/notch1 axis: a clue to bone metastasis.
Guo J; Tong CY; Shi JG; Li XJ; Chen XQ
Eur J Histochem; 2023 Jul; 67(3):. PubMed ID: 37491944
[TBL] [Abstract] [Full Text] [Related]
3. MicroRNA-143 acts as a tumor suppressor through Musashi-2/DLL1/notch1 and Musashi-2/Snail1/MMPs axes in acute myeloid leukemia.
Li F; Han Y; Chen R; Jiang Y; Chen C; Wang X; Zhou J; Xu Q; Jiang S; Zhang S; Yu K; Zhang S
J Transl Med; 2023 May; 21(1):309. PubMed ID: 37149661
[TBL] [Abstract] [Full Text] [Related]
4. Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma.
Jakubikova J; Cholujova D; Beke G; Hideshima T; Klucar L; Leiba M; Jamroziak K; Richardson PG; Kastritis E; Dorfman DM; Anderson KC
JCI Insight; 2023 Feb; 8(3):. PubMed ID: 36752202
[TBL] [Abstract] [Full Text] [Related]
5. CD7 CAR T bridging to allo-HSCT in R/R T-ALL: A case report.
Fanqiao M; Chen X; Ren X; Li L; Wu T
Pediatr Transplant; 2024 May; 28(3):e14367. PubMed ID: 35860981
[TBL] [Abstract] [Full Text] [Related]
6. CT Attenuation and Cross-sectional-area Index of the Pectoralis Are Associated With prognosis in Sarcoma Patients.
Jo S; Sebro R
Anticancer Res; 2021 Apr; 41(4):1927-1935. PubMed ID: 33813398
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic impact of notch1 receptor and clinicopathological High-Risk Predictors in lacrimal gland adenoid cystic carcinoma.
Anjum S; Sen S; Pushker N; Bajaj MS; Kashyap S; Bakhshi S; Chosdol K; Meel R; Sharma MC
Acta Ophthalmol; 2021 Dec; 99(8):e1467-e1473. PubMed ID: 33675181
[TBL] [Abstract] [Full Text] [Related]
8. Clinical Value of notch1 Mutations Detection among Chronic Lymphocytic Leukemia Patients.
Aref S; El-Agder M; Salama O; Abouzeid T; Sabry M
Asian Pac J Cancer Prev; 2020 May; 21(5):1295-1301. PubMed ID: 32458636
[TBL] [Abstract] [Full Text] [Related]
9. Central Nervous System-Invading Eccrine Gland Carcinoma: A Clinicopathologic Case Series and Literature Review.
Gupta S; Hulsbergen AFC; Segar DJ; Hauser BM; Bernstock JD; Nazarian RM; Lawrence DP; Nahed BV; Broekman MLD; Smith TR
World Neurosurg; 2020 Jun; 138():e17-e25. PubMed ID: 32142948
[TBL] [Abstract] [Full Text] [Related]
10. miR-139-mediated notch1 regulation is crucial for the inhibition of osteosarcoma progression caused by resveratrol.
Xiao X; Zhang Y; Pan W; Chen F
Life Sci; 2020 Feb; 242():117215. PubMed ID: 31881225
[TBL] [Abstract] [Full Text] [Related]
11. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.
Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J
BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559
[TBL] [Abstract] [Full Text] [Related]
12. Epigenetic Profiling Identifies LIF as a Super-enhancer-Controlled Regulator of Stem Cell-like Properties in Osteosarcoma.
Lu B; He Y; He J; Wang L; Liu Z; Yang J; Gao Z; Lu G; Zou C; Zhao W
Mol Cancer Res; 2020 Jan; 18(1):57-67. PubMed ID: 31615908
[TBL] [Abstract] [Full Text] [Related]
13. A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma.
Alegre F; Ormonde AR; Snider KM; Woolard K; Yu AM; Wittenburg LA
PLoS One; 2018; 13(12):e0209941. PubMed ID: 30596759
[TBL] [Abstract] [Full Text] [Related]
14. Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study.
Bonifazi F; Dan E; Labopin M; Sessa M; Guadagnuolo V; Ferioli M; Rizzi S; De Carolis S; Sinigaglia B; Motta MR; Bontadini A; Giudice V; Martinelli G; Arpinati M; Cavo M; Bonafé M; Storci G
Bone Marrow Transplant; 2019 May; 54(5):717-725. PubMed ID: 30232415
[TBL] [Abstract] [Full Text] [Related]
15. Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma.
Deng Y; Zhao F; Zhang Z; Sun F; Wang M
Cancer Biother Radiopharm; 2018 Nov; 33(9):365-372. PubMed ID: 29989838
[TBL] [Abstract] [Full Text] [Related]
16. Smoldering mantle cell lymphoma.
Ye H; Desai A; Zeng D; Nomie K; Romaguera J; Ahmed M; Wang ML
J Exp Clin Cancer Res; 2017 Dec; 36(1):185. PubMed ID: 29246179
[TBL] [Abstract] [Full Text] [Related]
17. Activating notch1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor prognosis, Propensity to bone and Liver Metastasis, and Potential Responsiveness to notch1 Inhibitors.
Ferrarotto R; Mitani Y; Diao L; Guijarro I; Wang J; Zweidler-McKay P; Bell D; William WN; Glisson BS; Wick MJ; Kapoun AM; Patnaik A; Eckhardt G; Munster P; Faoro L; Dupont J; Lee JJ; Futreal A; El-Naggar AK; Heymach JV
J Clin Oncol; 2017 Jan; 35(3):352-360. PubMed ID: 27870570
[TBL] [Abstract] [Full Text] [Related]
18. Translocation t(8;14)(q24;q11) with concurrent PTEN alterations and deletions of STIL/TAL1 and CDKN2A/B in a pediatric case of acute T-lymphoblastic leukemia: A genetic profile associated with adverse prognosis.
Skalska-Sadowska J; Dawidowska M; Szarzyńska-Zawadzka B; Jarmuż-Szymczak M; Czerwińska-Rybak J; Machowska L; Derwich K
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27759908
[TBL] [Abstract] [Full Text] [Related]
19. Expression of p53, p16, cyclin D1, epidermal growth factor receptor and notch1 in patients with temporal bone squamous cell carcinoma.
Morita S; Nakamaru Y; Homma A; Yasukawa S; Hatakeyama H; Sakashita T; Kano S; Fukuda A; Fukuda S
Int J Clin Oncol; 2017 Feb; 22(1):181-189. PubMed ID: 27488595
[TBL] [Abstract] [Full Text] [Related]
20. SRC Family Kinase Inhibition in Ewing Sarcoma Cells Induces p38 MAP Kinase-Mediated Cytotoxicity and Reduces Cell Migration.
Indovina P; Casini N; Forte IM; Garofano T; Cesari D; Iannuzzi CA; Del Porro L; Pentimalli F; Napoliello L; Boffo S; Schenone S; Botta M; Giordano A
J Cell Physiol; 2017 Jan; 232(1):129-35. PubMed ID: 27037775
[TBL] [Abstract] [Full Text] [Related]
[Next]
